Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitroglycerin in acute myocardial infarction.

B I Jugdutt1

  • 1Division of Cardiology, University of Alberta, Edmonton.

The Canadian Journal of Cardiology
|March 1, 1989
PubMed
Summary

Low-dose intravenous nitroglycerin is now considered safe and effective for acute myocardial infarction. This therapy improves heart function, reduces heart attack size, and lowers complication rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiotensin II antagonism. Cardioprotection and angiotensin receptor blockade.

IDrugs : the investigational drugs journal·2005
Same author

Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

British journal of pharmacology·2001
Same author

Effect of chronic AT(1) receptor antagonism on postischemic functional recovery and AT(1)/AT(2) receptor proteins in isolated working rat hearts.

Journal of cardiovascular pharmacology and therapeutics·2001
Same author

Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts.

Journal of hypertension·2001

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Nitroglycerin was previously contraindicated in acute myocardial infarction due to concerns about hypotension and reflex tachycardia.
  • Recent research has challenged this view, exploring its potential benefits.

Purpose of the Study:

  • To evaluate the safety and efficacy of low-dose intravenous nitroglycerin in acute myocardial infarction.
  • To assess its impact on myocardial infarct size and left ventricular performance.

Main Methods:

  • Animal studies demonstrated that prolonged low-dose infusion, titrated to a specific blood pressure reduction, increased collateral blood flow and decreased infarct size.
  • Clinical studies confirmed the safety and benefits in human patients.

Main Results:

  • Low-dose intravenous nitroglycerin, when carefully titrated, increases collateral blood flow and reduces infarct size in animal models.
  • Clinical trials show it is safe and improves left ventricular performance.
  • It also reduces infarct-related complications.

Conclusions:

  • Low-dose intravenous nitroglycerin is a safe and beneficial treatment for acute myocardial infarction.
  • It effectively reduces preload and afterload, improves cardiac function, and limits myocardial damage.

Related Experiment Videos